Pfizer Inc
(PFE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2000 | 06-2000 | 03-2000 | 12-1999 | 09-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,306,000 | 945,000 | -204,000 | 3,199,000 | 2,245,000 |
| Depreciation Amortization | 707,000 | 473,000 | 244,000 | 542,000 | 381,000 |
| Other Working Capital | 326,000 | 184,000 | 404,000 | -1,261,000 | -1,228,000 |
| Other Operating Activity | 206,000 | -306,000 | -392,000 | 576,000 | 380,000 |
| Operating Cash Flow | $3,545,000 | $1,296,000 | $52,000 | $3,056,000 | $1,778,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,801,000 | -339,000 | -841,000 | N/A | N/A |
| PPE Investments | -1,525,000 | -1,043,000 | -454,000 | -1,490,000 | -1,104,000 |
| Net Acquisitions | 168,000 | 168,000 | 79,000 | 26,000 | 0 |
| Purchase Of Investment | -349,000 | -333,000 | -1,000 | N/A | N/A |
| Sale Of Investment | 220,000 | 199,000 | 161,000 | N/A | N/A |
| Other Investing Activity | -73,000 | -95,000 | -25,000 | -1,304,000 | -1,482,000 |
| Investing Cash Flow | $-3,360,000 | $-1,443,000 | $-1,081,000 | $-2,768,000 | $-2,586,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,122,000 | 440,000 | 22,000 | N/A | N/A |
| Debt Issued | 18,000 | 8,000 | 1,550,000 | N/A | N/A |
| Debt Repayment | -20,000 | -3,000 | N/A | N/A | N/A |
| Common Stock Issued | 923,000 | 712,000 | 319,000 | N/A | N/A |
| Common Stock Repurchased | -626,000 | N/A | N/A | N/A | N/A |
| Dividend Paid | -1,642,000 | -1,088,000 | -541,000 | -1,148,000 | -851,000 |
| Other Financing Activity | -979,000 | -695,000 | -1,318,000 | 21,000 | 1,073,000 |
| Financing Cash Flow | $-1,204,000 | $-626,000 | $32,000 | $-1,127,000 | $222,000 |
| Exchange Rate Effect | 2,000 | 5,000 | -1,000 | 26,000 | -24,000 |
| Beginning Cash Position | 2,358,000 | 2,358,000 | 2,358,000 | 1,552,000 | 1,552,000 |
| End Cash Position | 1,341,000 | 1,590,000 | 1,360,000 | 739,000 | 942,000 |
| Net Cash Flow | $-1,017,000 | $-768,000 | $-998,000 | $-813,000 | $-610,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,545,000 | 1,296,000 | 52,000 | 3,056,000 | 1,778,000 |
| Capital Expenditure | -1,525,000 | -1,043,000 | -454,000 | N/A | N/A |
| Free Cash Flow | 2,020,000 | 253,000 | -402,000 | 3,056,000 | 1,778,000 |